CT/NG Testing Market Outlook and Revenue Forecast 2026 to 2035

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CT/NG Testing Market- (By Product (Assays & kits, Instruments/Analyzers), By Test Type (Laboratory, Point-of-care testing), By Technology (INAAT, PCR, Immunodiagnostics, Others), By End-User (Diagnostics & Laboratories, Hospitals & Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2035."

CT/NG Testing Market Size is valued at USD 1.95 Bn in 2025 and is predicted to reach USD 5.19 Bn by the year 2035 at a 10.32% CAGR during the forecast period for 2026 to 2035.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1984

Chlamydia is one of the most common sexually transmitted infections (STIs) and is caused by the bacterium Chlamydia trachomatis. In many cases, particularly among women, the infection is asymptomatic; however, if left untreated, it can lead to serious reproductive health complications such as pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain.

Gonorrhea, resulting from infection with Neisseria gonorrhoeae, is another highly prevalent STI, with a disproportionately high incidence among young adults. Populations at elevated risk include individuals with multiple sexual partners, those with co-existing STIs, men who have sex with men (MSM), and persons involved in commercial sex work.

The rising global burden of STIs, together with growing public awareness and the implementation of supportive government programs focused on early detection and timely treatment, is a key factor driving growth in the Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) diagnostics and therapeutics market.

List of Prominent Players in the CT/NG Testing Market:
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Hologic, Inc. (US),
• Thermo Fisher Scientific Inc. (US),
• Abbott Laboratories (US),
• Bio-Rad Laboratories, Inc. (US),
• Siemens Healthineers AG (Germany),
• Danaher (US),
• Becton,
• Dickinson and Company (US)

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics
Drivers:
The Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing market is experiencing strong growth, largely supported by government-backed initiatives, grant programs, and policy frameworks that promote innovation in diagnostic technologies. These funding mechanisms enable companies to invest in research and development, expand laboratory capabilities, and commercialize next-generation testing solutions.

Improved access to capital is accelerating advancements in CT/NG diagnostics, enhancing disease screening, surveillance, and precision treatment approaches. Collaborative programs between healthcare providers, community organizations, and diagnostic developers have further strengthened testing and treatment capacity, reinforcing market momentum.

Challenges:
The economics of CT/NG testing are influenced by variable costs associated with reagents, proprietary diagnostic platforms, and vendor-specific implementation fees. In addition, ongoing expenses related to equipment maintenance, insurance, laboratory operations, and facility management add to the overall financial burden. Consequently, large hospitals and centralized reference laboratories are better positioned to adopt and sustain advanced diagnostic systems, while smaller laboratories, clinics, and independent practices often face budgetary constraints. The high capital requirements for CT/NG diagnostic instruments and test kits remain a significant barrier to entry and may limit broader market penetration.

Regional Trends:
The Asia-Pacific region is expected to record the fastest growth rate over the forecast period, driven by the increasing prevalence of sexually transmitted infections in emerging economies. Expansion is further supported by public health awareness programs, enhanced education initiatives, and strong government involvement in strengthening healthcare infrastructure and access to diagnostic services. Together, these factors are anticipated to accelerate adoption of CT/NG testing solutions across the region.

Recent Developments:
• In May 2022, - Abbott said that its Alinity m STI Assay had been approved by the FDA. The test finds and separates four common sexually transmitted diseases (STIs) at the same time. If STIs aren't addressed, they can cause serious health problems, like an increased chance of getting certain cancers or being unable to have children.
• In Oct 2022, Bio-Rad released two Exact Diagnostics molecular controls. The CT/NG Positive Run Control was designed for molecular tests of Chlamydia trachomatis and N. gonorrhoeae. The company said the STI Negative Run Control monitored the absence of Chlamydia trachomatis and Neisseria gonorrhoeae in molecular assays and could be used to detect laboratory testing errors, including contamination events while controlling for sample adequacy.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1984

Segmentation of CT/NG Testing Market-
By Product-
• Assays & kits
• Instruments/Analyzers
By Test Type-
• Laboratory,
• Point-of-care testing
By Technology-
• INAAT,
• PCR,
• Immunodiagnostics
• Others
By End-User-
• Diagnostics & Laboratories
• Hospitals & Clinics
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/ctng-testing-market/1984

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.